THIS PRESENTATION ABOUT ANTIMALARIAL DRUGS DETAILING THE COMPLETE INFORMATION ABOUT THE DRUGS USED WITH ITS MECHANISM OF ACTION, STRUCTURAL ACTIVITY AND DOSES.
-a broad-spectrum antibiotics.
-It is commonly used to treat acne, infection, and other infections caused by bacteria.
-The first of these compounds was chlortetracycline followed by oxytetracycline and tetracycline.
Tetracycline is a broad-spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria, indicated for use against many bacterial infections. It is a protein synthesis inhibitor. It is commonly used to treat acne today, and, more recently, rosacea, and is historically important in reducing the number of deaths from cholera. Tetracycline is marketed under the brand names Sumycin, Tetracyn, and Panmycin, among others. Actisite is a thread-like fiber formulation used in dental applications. It is also used to produce several semisynthetic derivatives, which together are known as the tetracycline antibiotics. The term "tetracycline" is also used to denote the four-ring system of this compound; "tetracyclines" are related substances that contain the same four-ring system.
Aminoglycosides(medicinal chemistry by p.ravisankar)Dr. Ravi Sankar
Aminoglycosides,Aminocyclitols,Source,Structures of streptomycin,Dihydrostreptomycin,A mention of other aminoglycoside antibiotics,Acid hydrolysis,Mechanism of action,SAR,Dihydrostreptomycin and its importance,therapeutic uses, toxicity.
THIS PRESENTATION ABOUT ANTIMALARIAL DRUGS DETAILING THE COMPLETE INFORMATION ABOUT THE DRUGS USED WITH ITS MECHANISM OF ACTION, STRUCTURAL ACTIVITY AND DOSES.
-a broad-spectrum antibiotics.
-It is commonly used to treat acne, infection, and other infections caused by bacteria.
-The first of these compounds was chlortetracycline followed by oxytetracycline and tetracycline.
Tetracycline is a broad-spectrum polyketide antibiotic produced by the Streptomyces genus of Actinobacteria, indicated for use against many bacterial infections. It is a protein synthesis inhibitor. It is commonly used to treat acne today, and, more recently, rosacea, and is historically important in reducing the number of deaths from cholera. Tetracycline is marketed under the brand names Sumycin, Tetracyn, and Panmycin, among others. Actisite is a thread-like fiber formulation used in dental applications. It is also used to produce several semisynthetic derivatives, which together are known as the tetracycline antibiotics. The term "tetracycline" is also used to denote the four-ring system of this compound; "tetracyclines" are related substances that contain the same four-ring system.
Aminoglycosides(medicinal chemistry by p.ravisankar)Dr. Ravi Sankar
Aminoglycosides,Aminocyclitols,Source,Structures of streptomycin,Dihydrostreptomycin,A mention of other aminoglycoside antibiotics,Acid hydrolysis,Mechanism of action,SAR,Dihydrostreptomycin and its importance,therapeutic uses, toxicity.
THE PRODRUG DESIGNING FOR NEW SELECTION AND FORMULATION OF DRUG COMPATIBLE WITH API I.E. ACTIVE PHARMACUTICAL INGREDIENT, AND ITS EFFECT WHICH SHOULD BE 0. THE DRUG COMBINED WITH API AND AVILABLE IN MARKET AND DRUGS NEED TO BE COMBINE ARE ALSO DISCUSSED WITH ITS STRUCTURE AND SAR, AND COVERED AS PER THE SYLLABUS OF PCI.
These are antibiotics having a macrocyclic
lactone ring with attached sugars. Erythromycin
is the first member discovered in the 1950s,
Roxithromycin, Clarithromycin and Azithromycin
are the later additions. Antimicrobial spectrum is narrow,
includes mostly gram-positive and a few gramnegative
bacteria, and overlaps considerably with
that of penicillin G. Erythromycin is highly active
against Str. pyogenes and Str. pneumoniae, N.
gonorrhoeae, Clostridia, C. diphtheriae and
Listeria, but penicillin-resistant Staphylococci
and Streptococci are now resistant to erythromycin
also.
All cocci readily develop resistance
to erythromycin, mostly by acquiring the
capacity to pump it out. Resistant Enterobacteriaceae
have been found to produce an erythromycin
esterase. Alteration in the ribosomal binding
site for erythromycin by a plasmid encoded
methylase enzyme is an important mechanism of
resistance in gram-positive bacteria. All the above
types of resistance are plasmid mediated. Change
in the 50S ribosome by chromosomal mutation
reducing macrolide binding a
Tetracyclines,Biological sources,History,Sturctures,SAR,Mechanism of action,Spectrum of activity,Important structural units and the three acidity constants in the tetracycline molucule,amphoteric nature,epimerisation, chelation with metals,toxicity and uses.
The cephalosporins are β-lactam antibiotics isolated from Cephalosporium spp. or prepared semisynthetically
Most of the antibiotics introduced since 1965 have been semisynthetic cephalosporins.
THE PRODRUG DESIGNING FOR NEW SELECTION AND FORMULATION OF DRUG COMPATIBLE WITH API I.E. ACTIVE PHARMACUTICAL INGREDIENT, AND ITS EFFECT WHICH SHOULD BE 0. THE DRUG COMBINED WITH API AND AVILABLE IN MARKET AND DRUGS NEED TO BE COMBINE ARE ALSO DISCUSSED WITH ITS STRUCTURE AND SAR, AND COVERED AS PER THE SYLLABUS OF PCI.
These are antibiotics having a macrocyclic
lactone ring with attached sugars. Erythromycin
is the first member discovered in the 1950s,
Roxithromycin, Clarithromycin and Azithromycin
are the later additions. Antimicrobial spectrum is narrow,
includes mostly gram-positive and a few gramnegative
bacteria, and overlaps considerably with
that of penicillin G. Erythromycin is highly active
against Str. pyogenes and Str. pneumoniae, N.
gonorrhoeae, Clostridia, C. diphtheriae and
Listeria, but penicillin-resistant Staphylococci
and Streptococci are now resistant to erythromycin
also.
All cocci readily develop resistance
to erythromycin, mostly by acquiring the
capacity to pump it out. Resistant Enterobacteriaceae
have been found to produce an erythromycin
esterase. Alteration in the ribosomal binding
site for erythromycin by a plasmid encoded
methylase enzyme is an important mechanism of
resistance in gram-positive bacteria. All the above
types of resistance are plasmid mediated. Change
in the 50S ribosome by chromosomal mutation
reducing macrolide binding a
Tetracyclines,Biological sources,History,Sturctures,SAR,Mechanism of action,Spectrum of activity,Important structural units and the three acidity constants in the tetracycline molucule,amphoteric nature,epimerisation, chelation with metals,toxicity and uses.
The cephalosporins are β-lactam antibiotics isolated from Cephalosporium spp. or prepared semisynthetically
Most of the antibiotics introduced since 1965 have been semisynthetic cephalosporins.
002. Cephalosporins for students 2023 Prof. P. Ravisankar.pdfDr. Ravi Sankar
Cephalosporins, Why Cephalosporins? Advantages of cephalosporins over penicillin, Mechanism of action of cephalosporins, Classification of cephalosporins, Structures of some important cephalosporins and cephamycins, Oximinocephalosporins, SAR of cephalosporins,Hydrolytic reactions, degradation and stability of cephalosporins, Uses of cephalosporins, Comparison between 6-APA and 7-ACA and penam and cepham.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
How to Give Better Lectures: Some Tips for Doctors
Cephalosporins MHG .pdf
1. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 1 of 11
CEPHALOSPORINS
Cephalosporins are another most important part of β-lactam category/ class
antibiotic apart from penicillins.
Figure: Different structural analogs of β-lactam class of antibiotics
The only structural difference/ comparison between PC & CP is
2. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 2 of 11
This structural difference makes CP different than PC in following manners
o Spectrum of activity
Narrow / broad
Against G-ve/ G+ve
o Route of administration
Parenteral/ oral
o Improved pharmacokinetic properties etc
All commercially available cephalosporins and cephamycins are named 3-
cephems (or Δ3
-cephems) to designate the position of the double bond.
To date, the more useful/ better semi-synthetic modifications of the basic 7-ACA
nucleus have been resulted from
o acylations of the 7-amino group with different acids or
o nucleophilic substitution or
o reduction of the acetoxyl group.
3. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 3 of 11
Basic nomenclature & numbers
The chemical nomenclature of the cephalosporins is slightly complex than even
that of the penicillins because of the presence of a double bond in the
dihydrothiazine ring.
Chemistry
The fused ring system is designated by Chemical Abstracts as 5-thia-1-
azabicyclo[4.2.0]oct-2-ene.
In another system of nomenclature (USP) cephalothin is 3-(acetoxymethyl)-7-[2-
(thienylacetyl)amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct- 2-ene-2-carboxylic
acid.
A simplification that retains some of the systematic nature of the Chemical
Abstracts procedure names the saturated bicyclic ring system with the lactam
carbonyl oxygen cepham (≈cf., penam for penicillins).
4. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 4 of 11
According to this system, all commercially available cephalosporins and
cephamycins are named 3-cephems (or Δ3
-cephems) to designate the position
of the double bond. (Interestingly, all known 2-cephems are inactive, presumably
because the β-lactam lacks the necessary ring strain to react sufficiently.)
some cephalosporins are named as derivatives of cephalosporanic acids, this
practice applies only to the derivatives that have a 3-acetoxymethyl group.
Spectrum of Activity
The cephalosporins are considered broad-spectrum antibiotics with patterns of
antibacterial effectiveness comparable to that of ampicillin.
Cephalosporins are much more resistant to inactivation by β-lactamases,
particularly those produced by G+ve bacteria, than is ampicillin.
Ampicillin, however, is generally more active against non–β-lactamase-producing
strains of Gram-positive and Gram-negative bacteria sensitive to both it and the
cephalosporins.
Cephalosporins, exhibit uniquely potent activity against most species of Klebsiella.
Structure Activity and Relationship
The most important variable characteristics which prompts structural modification
probably are due to
(a) resistance to inactivation by β-lactamases,
(b) permeability of bacterial cells, and
(c) intrinsic activity against bacterial enzymes involved in cell wall synthesis and
cross-linking.
5. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 5 of 11
Structure–activity relationships (SARs) among the cephalosporins appear to
parallel those among the penicillins insofar as the acyl group is concerned.
The presence of an allylic acetoxyl function in the 3-position, however,
provides a reactive site at which various 7-acylaminocephalosporanic acid
structures can easily be varied by nucleophilic displacement reactions.
Perhaps the most noteworthy development thus far is the discovery that 7-
phenylglycyl derivatives of 7-ACA and especially 7-ADCA are active orally.
Phenyl glycyl
In the preparation of semi-synthetic cephalosporins, the following improvements
are sought:
(a) Increased acid stability,
(b) Improved pharmacokinetic properties, particularly better oral absorption,
(c) broadened antimicrobial spectrum,
(d) increased activity against resistant microorganisms (as a result of
resistance to enzymatic destruction,
improved penetration,
Increased receptor affinity, etc.),
6. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 6 of 11
(e) Decreased allergenicity, and
(f) Increased tolerance after parenteral administration.
Oral Cephalosporins
The oral activity conferred by the phenylglycyl substituent is attributed to
increased acid stability of the lactam ring,
This resulted from the presence of a protonated amino group on the 7-acylamino
portion of the molecule.
Phenyl glycyl
Carrier mediated transport of these dipeptide-like, zwitterionic
cephalosporins is also an important factor in their excellent oral activity.
The situation, then, is analogous to that of the α-aminobenzylpenicillins (e.g.,
ampicillin).
Also important for high acid stability (and, therefore, good oral activity) of the
cephalosporins is the absence of the leaving group at the 3-position.
Structural comparison & difference between oral & parenteral cephalosporins
7. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 7 of 11
Thus, despite the presence of the phenylglycyl side chain in its structure, the
cephalosporanic acid derivative cephaloglycin is poorly absorbed orally,
presumably because of solvolysis of the 3-acetoxyl group in the low pH of
the stomach.
The resulting 3-hydroxyl derivative undergoes lactonization under acidic
conditions.
The 3-hydroxyl derivatives and, especially, the corresponding lactones are
considerably less active in vitro than the parent cephalosporins.
Generally, acyl derivatives of 7-ADCA show lower in vitro antibacterial
potencies than the corresponding 7-ACA analogs.
Example
Oral activity can also be conferred in certain cephalosporins by esterification of
the 3-carboxylic acid group to form acid-stable, lipophilic esters that
undergohydrolysis in the plasma.
Cefuroxime axetil and cefpodoxime proxetil are two β-lactamase–resistant
alkox-imino-cephalosporins that are orally active ester prodrug derivatives of
cefuroxime and cefpodoxime, respectively, based on this concept.
Alkox-imino-cephalosporins that are orally active ester prodrug
8. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 8 of 11
Parenteral Cephalosporins
ORAL PARENTERAL
Hydrolysis of the ester function, catalyzed by hepatic and renal esterases, is
responsible for some in vivo inactivation of parenteral cephalosporins
containing a 3-acetoxymethyl substituent (e.g., cephalothin, cephapirin, and
cefotaxime).
The extent of such inactivation (20-35%) is not large enough to seriously
compromise the in vivo effectiveness of acetoxyl cephalosporins.
Parenteral cephalosporins lacking a hydrolyzable group at the 3-position are not
subject to hydrolysis by esterases.
Cephradine is the only cephalosporin that is used both orally and parenterally.
β-Lactamase Resistance
The susceptibility of cephalosporins to various β lactamases varies considerably
with the source and properties of these enzymes.
Thus, of several cephalosporins tested in vitro,
o cephalothin and cefoxitin are the most resistant, and
o cephaloridine and cefazolin are the least resistant.
The same acyl functionalities that impart β -lactamase resistance in the
penicillins unfortunately render cephalosporins virtually inactive against S. aureus
and other Gram-positive bacteria.
9. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 9 of 11
The “penicillinase” resistance of cephalosporins appears to be a property
of the bicyclic cephem ring system rather than of the acyl group.
The introduction of polar substituents in the aminoacyl moiety of cephalosporins
appears to confer stability to some β lactamases.
Thus examples of resistant to a few β lactamases cephalo’s are
o cefamandole and cefonicid, which contain an α-hydroxyphenylacetyl (or
mandoyl) group, and
o ceforanide, which has an o-aminophenyl acetyl group
Steric factors also may be important because cefoperazone, an acylureido
cephalosporin that contains the same 4-ethyl-2,3-dioxo-1-piperazinylcarbonyl
Two structural features confer broadly based resistance to β lactamases among
the cephalosporins:
o an alkoximino function in the aminoacyl group and
o a methoxyl substituent at the 7-position of the cephem nucleus having α-
stereochemistry.
The structures of several β lactamase–resistant cephalosporins, including
cefuroxime, cefotaxime, ceftizoxime and ceftriaxone, feature a methoximino
acyl group.
β Lactamase resistance is enhanced modestly if the oximino substituent also
features a polar function, as in ceftazidime, which has a 2-methylpropionic
acid substituent on the oximino group.
Both steric and electronic properties of the alkoximino group may
contribute to the β-lactamase resistance conferred by this functionality
since syn-isomers are more potent than anti-isomers.
β Lactamase–resistant 7α-methoxylcephalosporins, also called cephamycins
because they are derived from cephamycin C (an antibiotic isolated from
Streptomyces), are represented by cefoxitin, cefotetan, cefmetazole, and the
1-oxocephalosporin moxalactam, which is prepared by total synthesis.
Anti-pseudomonal Cephalosporins
10. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 10 of 11
Species of Pseudomonas, especially P. aeruginosa, represent a special public
health problem because of their ubiquity in the environment and their propensity
to develop resistance to antibiotics, including the β -lactams.
The primary mechanisms of β lactam resistance appear to involve destruction
of the antibiotics by β lactamases and/or interference with their penetration
through the cell envelope.
Apparently, not all β lactamase–resistant cephalosporins penetrate the cell
envelope of P. aeruginosa, as only
o cefoperazone,
o moxalactam,
o cefotaxime,
o ceftizoxime,
o ceftriaxone, and
o ceftazidime
have useful antipseudomonal activity.
Two cephalosporins,
o moxalactam and
o cefoperazone,
contain the same polar functionalities (e.g., carboxy and N-acylureido) that
facilitate penetration into Pseudomonas spp. by the penicillins (see carbenicillin,
ticarcillin, and piperacillin).
Unfortunately, strains of P. aeruginosa resistant to cefoperazone and cefotaxime
have been found in clinical isolates.
Classification
Cephalosporins are divided into first-, second-, third-, and fourth-generation agents,
based roughly
on their time of discovery and
their antimicrobial properties (Table 8.5).
11. Cephalosporin’s-MC-III [Compiled & Edited ByDr M H Ghante]
Page 11 of 11
In general, progression from first to fourth generation is associated with a
broadening of the Gram-negative antibacterial spectrum,
some reduction in activity against Gram-positive organisms,
and enhanced resistance to -β lactamases.
Individual cephalosporins differ in their pharmacokinetic properties, especially plasma
protein binding and half-life, but the structural bases for these differences are not
obvious.
1st
Generation Oral Ceph-a-lexin, Cef-a-droxi, Ceph-a-ridine
Parenteral Cef-a-zolin
2nd
Generation Oral
Cef-a-clor (exception), Cefuroxi-me axetil
(exception), Loracarbef, Cefprozil
Parenteral Cefuroxime, Cefotetan, Cefoxitin, Cefmetazole
3rd
Generation
Oral
Cefixi-me, Cefpodoxi-me axetil, Ceftibuten
Cefditoren, Cefdinir
Parenteral
Cefotaxi-me, Ceftizoxi-me, Ceftriaxone, Ceftazidi-
me, Cefoperazone, Moxalactam
4th
Generation Parenteral Cefi-pi-me, Cefi-pi-rome
5th
Generation Parenteral Cefta-ro-line, Ceftobip-ro-le
Summary of β lactamase resistance cephalosporins
Functional group Chemical groups Examples
bicyclic cephem ring
Confers
resistance
polar substituents in
the aminoacyl
moiety
α-OH yphenylacetyl
cefamandole &
cefonicid
o-NH2phenyl acetyl
group
ceforanide
Steric factors &
resistance
an acylureido
cephalosporin
4-ethyl-2,3-dioxo-1-
piperazinylcarbonyl
cefoperazone,
β lactamase–
resistance
methoximino acyl
group
cefuroxime, cefotaxime, ceftizoxime &
ceftriaxone
modestly
enhanced
oximino substituent
a polar function
ceftazidime